Product Details

Vaniqa (Eflornithine Hydrochloride) cream for reduction of unwanted facial hair for women.

WHAT IS VANIQA?

Vaniqa (eflornithine hydrochloride) is a prescription medication for the reduction of unwanted facial hair in women. Designed for application to the skin, Vaniqa should only be used on the face and adjacent areas under the chin of affected individuals. Results can be seen as early as 4-8 weeks when used twice a day, at least 8 hours apart. Tested in women of multiple ethnicities.

HOW IT WORKS

Vaniqa works by slowing down the growth of facial hair. It works during the growth stage of the hair cycle by interfering with an enzyme in the follicle necessary for the hair to grow.

CHOOSING STRENGTH

Vaniqa (eflornithine hydrochloride) 13.9% is available in a 60g tube for use on the face and adjacent areas under the chin.

HOW TO USE IT

Vaniqa is designed for application to the face and adjacent areas under the chin. Detailed information on how to apply Vaniqa can be found in the patient information leaflet.

Vaniqa is applied twice daily, 8 hours apart, to areas on the face or chin with increased hair growth. Vaniqa has not been tested for use on other parts of the body and, as such, should only be used on the face.

Vaniqa takes time to work, however, improvements may be visible after 4-8 weeks depending on the individual and the severity of the condition.

SIDE-EFFECTS

Like all prescription medication, Vaniqa may cause side effects. Should any side effects occur you are advised to contact your GP.

Side effects are usually mild in nature and limited to the skin. In these cases, they can be resolved without having to discontinue use of Vaniqa.

Very common (affects more than 1 user in 10):

• Acne

Common (affects 1 to 10 users in 100):

• Dry skin
• Hair Loss
• Mild skin irritation (rashes, itching, redness)

Uncommon (affects 1 to 10 users in 1,000):

• Cold sores
• Eczema
• Ingrowing hairs
• Papular rash
• More severe inflammation of the skin (possibly resulting in boils, bleeding or more pronounced flushing)
• Swelling around the facial area
• Unusual hair texture or growth

Rare (affects 1 to 10 users in 10,000):

• Excessive hair growth
• Abnormal skin growth
• Spots
• Tight skin
• Cysts on the skin
• Rashes that blister
• Red, scaly and itchy skin inflammation (Seborrhoeic dermatitis)

PATIENT INFORMATION LEAFLET

Please read the patient information leaflet for more detailed information prior to placing any orders

https://www.medicines.org.uk/emc/files/pil.6398.pdf